OneMedNet Corporation (ONMD) Price Target Analysis

Analyst Rating:

Based on 0 analysts

No Target Data

ONMD trades at Wall Street's consensus target of —.

Current Price$0.71

Average Target—

Low—

Median—

High—

Analyst Target Range

Forward P/E—

PEG Ratio—

Implied Growth—

Analyst Spread—

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$0.71

Consensus—

High—

Low—

Consensus Scenario Assumptions

The base valuation assumes ONMD achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of multiple Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings

No analyst coverage available for ONMD

Coverage appears once Wall Street estimates are published.

ONMD Price Target Analysis

Updated July 8, 2026

As of July 8, 2026, OneMedNet Corporation (ONMD) has a Wall Street consensus price target of N/A, based on estimates from 0 covering analysts. The company has a market capitalization of $39M.

Analyst price targets range from a low of N/A to a high of N/A.

The current analyst consensus rating is N/A, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.

From a valuation perspective, ONMD trades at a trailing P/E of -11.8x.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis

Avg Peer Upside

+38.8%

Industry Consensus

Avg Forward P/E

27.2x

(Growth Premium)

Peers with Coverage

9 / 10

Active Analyst Tracking

Company	Market Cap	Price	Target	Upside Potential	Rating	Fwd P/E	Analysts
NVCRNovoCure Limited	$2.0B	$17.72	$33.00	+86.2%	Buy	—	15
HCATHealth Catalyst, Inc.	$168M	$2.27	$2.13	-6.2%	Buy	54.2x	22
DOCSDoximity, Inc.	$4.3B	$22.74	$29.47	+29.6%	Hold	15.9x	23
PHVSPharvaris N.V.	$2.3B	$34.59	$53.50	+54.7%	Buy	—	12
INVAInnoviva, Inc.	$1.6B	$22.25	$37.00	+66.3%	Buy	6.2x	10
MTEXMannatech, Incorporated	$10M	$5.25	—	—	—	—	—
VEEVVeeva Systems Inc.	$31.2B	$192.30	$235.38	+22.4%	Buy	21.2x	43
ISRGIntuitive Surgical, Inc.	$151.3B	$427.30	$597.78	+39.9%	Buy	40.9x	55
GEHCGE HealthCare Technologies Inc.	$29.5B	$64.89	$81.00	+24.8%	Buy	13.3x	18
IDXXIDEXX Laboratories, Inc.	$45.3B	$570.25	$747.50	+31.1%	Buy	38.9x	22

ONMD — Frequently Asked Questions

Quick answers to the most common questions about buying ONMD stock.

What is the ONMD stock price target for 2026?

The consensus price target for ONMD is $N/A, close to the current price of $0.711 (N/A% implied move). Based on 0 analyst estimates, the stock appears fairly valued near current levels.

Is ONMD a buy, sell, or hold?

ONMD has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

Is ONMD stock overvalued or undervalued?

ONMD's current price is $0.711 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.

How high can ONMD stock go?

The most bullish Wall Street analyst has a price target of $N/A for ONMD, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover ONMD stock?

ONMD is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the ONMD stock forecast?

The 12-month ONMD stock forecast based on 0 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "N/A".

Should I buy ONMD stock?

ONMD appears fairly valued according to analysts, with a "N/A" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do ONMD price targets vary so much?

ONMD analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.

Consensus-Based Analysis Tools